| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| host | mouse |
| isotype | IgG |
| clonality | monoclonal |
| concentration | concentrate, predilute |
| applications | IHC |
| reactivity | human |
| available size | 0.1 mL, 0.5 mL, 1 mL concentrated, 7 mL prediluted |
rabbit anti-CD38 monoclonal antibody (ZR351) 6090
Price range: $160.00 through $528.00
Antibody summary
- Rabbit monoclonal to CD38
- Suitable for: Immunohistochemistry (formalin-fixed, paraffin-embedded tissues)
- Reacts with: Human
- Isotype:IgG
- Control: Tonsil
- Visualization: Cytoplasmic
- 0.1, 0.5, 1.0 mL concentrated, 7 mL prediluted
rabbit anti-CD38 monoclonal antibody ZR351 6090
| target relevance |
|---|
| Protein names ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPR hydrolase 1) (T10) (CD antigen CD38) |
| Gene names CD38,CD38 |
| Protein family ADP-ribosyl cyclase family |
| Mass 34328Da |
| Function FUNCTION: Synthesizes cyclic ADP-ribose (cADPR), a second messenger for glucose-induced insulin secretion (PubMed:7961800, PubMed:8253715). Synthesizes the Ca(2+) mobilizer nicotinate-adenine dinucleotide phosphate, NAADP(+), from 2'-phospho-cADPR and nicotinic acid, as well as from NADP(+) and nicotinic acid. At both pH 5.0 and pH 7.4 preferentially transforms 2'-phospho-cADPR into NAADP(+), while preferentially cleaving NADP(+) to cADPR and ADPRP rather than into NADDP(+) (PubMed:16690024). Has cADPR hydrolase activity (PubMed:7961800, PubMed:8253715). {ECO:0000269|PubMed:16690024, ECO:0000269|PubMed:7961800, ECO:0000269|PubMed:8253715}. |
| Catalytic activity CATALYTIC ACTIVITY: Reaction=2'-phospho-cyclic ADP-ribose + nicotinate = nicotinate-adenine dinucleotide phosphate; Xref=Rhea:RHEA:38607, ChEBI:CHEBI:32544, ChEBI:CHEBI:75967, ChEBI:CHEBI:75970; Evidence={ECO:0000269|PubMed:16690024}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38608; Evidence={ECO:0000269|PubMed:16690024}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38609; Evidence={ECO:0000269|PubMed:16690024}; CATALYTIC ACTIVITY: Reaction=NAD(+) = cyclic ADP-beta-D-ribose + nicotinamide + H(+); Xref=Rhea:RHEA:38611, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:73672; Evidence={ECO:0000269|PubMed:7961800, ECO:0000269|PubMed:8253715}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38612; Evidence={ECO:0000269|PubMed:8253715}; CATALYTIC ACTIVITY: Reaction=NAD(+) + H2O = ADP-D-ribose + nicotinamide + H(+); Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6; Evidence={ECO:0000269|PubMed:16690024, ECO:0000269|PubMed:8253715}; CATALYTIC ACTIVITY: Reaction=cyclic ADP-beta-D-ribose + H2O = ADP-D-ribose; Xref=Rhea:RHEA:38615, ChEBI:CHEBI:15377, ChEBI:CHEBI:57967, ChEBI:CHEBI:73672; Evidence={ECO:0000269|PubMed:7961800, ECO:0000269|PubMed:8253715}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38616; Evidence={ECO:0000269|PubMed:8253715}; CATALYTIC ACTIVITY: Reaction=NADP(+) = 2'-phospho-cyclic ADP-ribose + nicotinamide; Xref=Rhea:RHEA:38603, ChEBI:CHEBI:17154, ChEBI:CHEBI:58349, ChEBI:CHEBI:75970; Evidence={ECO:0000269|PubMed:16690024}; CATALYTIC ACTIVITY: Reaction=nicotinate + NADP(+) = nicotinate-adenine dinucleotide phosphate + nicotinamide; Xref=Rhea:RHEA:38599, ChEBI:CHEBI:17154, ChEBI:CHEBI:32544, ChEBI:CHEBI:58349, ChEBI:CHEBI:75967; EC=2.4.99.20; Evidence={ECO:0000305|PubMed:16690024}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38600; Evidence={ECO:0000305|PubMed:16690024}; |
| Subellular location SUBCELLULAR LOCATION: Cell surface {ECO:0000269|PubMed:2319135}. Membrane {ECO:0000269|PubMed:8253715}; Single-pass type II membrane protein. |
| Tissues TISSUE SPECIFICITY: Expressed at high levels in pancreas, liver, kidney, brain, testis, ovary, placenta, malignant lymphoma and neuroblastoma. {ECO:0000269|PubMed:8253715, ECO:0000269|PubMed:9074508}. |
| Structure SUBUNIT: Homodimer. {ECO:0000305|PubMed:16154090}. |
| Target Relevance information above includes information from UniProt accession: P28907 |
| The UniProt Consortium |
Data
![]() |
| Human tonsil stained with anti-CD38 antibody using peroxidase-conjugate and DAB chromogen. Note cytoplasmic staining of perifollicular and subepithelial plasma cells. |
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Protocols
| relevant to this product |
|---|
| IHC |
Documents
| # | SDS | Certificate | |
|---|---|---|---|
| Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. | |||
Only logged in customers who have purchased this product may leave a review.
















Reviews
There are no reviews yet.